CBD Global Sciences EV/EBITDA
What is the EV/EBITDA of CBD Global Sciences?
The EV/EBITDA of CBD Global Sciences Inc. is N/A
What is the definition of EV/EBITDA?
EV/EBITDA is enterprise value divided by earnings before interest, tax, depreciation, and amortization. It is a measure of how expensive a stock is and is more frequently valid for comparisons across companies than the price to earnings ratio. It measures the price (in the form of enterprise value) an investor pays for the benefit of the company’s cash flow (in the form of EBITDA).
= enterprise value / EBITDA
Price to earnings ratios are impacted by a company's choice of capital structure - companies which raise money via debt will have lower P/Es (and therefore look cheaper) than companies that raise an equivalent amount of money by issuing shares, even though the two companies might have equivalent enterprise values. A sample case is when a company with debt were to raise money by issuing shares of stock, and then used the money to pay off the debt, this company's P/E ratio would shoot up because of the increased number of shares - although nothing about the fundamental value of the business has changed. EV / EBITDA is unaffected by capital structure as enterprise value includes the value of debt, and EBITDA is available to all investors (debt and equity) as it excludes interest payments on that debt. It is ideal for analysts and potential investors looking to compare companies within the same industry.
EV/EBITDA of companies in the Health Care sector on OTC compared to CBD Global Sciences
What does CBD Global Sciences do?
CBD Global Sciences Inc. engages in cannabidiol (CBD) farming, processing, and product manufacturing business. It offers provides biomass, CBD oil, and CBD oil products under the Aethics, CannaOil, and Strasburg Pharms brand names. The company was incorporated in 2018 and is headquartered in Lakewood, Colorado.
Companies with ev/ebitda similar to CBD Global Sciences
- Atomo Diagnostics has EV/EBITDA of N/A
- LXRandCo has EV/EBITDA of N/A
- Exro Technologies Inc has EV/EBITDA of N/A
- Pacific Imperial Mines has EV/EBITDA of N/A
- Kalina Power has EV/EBITDA of N/A
- TransAtlantic Petroleum Ltd has EV/EBITDA of N/A
- CBD Global Sciences has EV/EBITDA of N/A
- Paradigm Biopharmaceuticals has EV/EBITDA of N/A
- Guided Therapeutics has EV/EBITDA of N/A
- KRM22 Plc has EV/EBITDA of N/A
- CMC Metals has EV/EBITDA of N/A
- Lamaska Capital has EV/EBITDA of N/A
- Riverside Resources has EV/EBITDA of N/A